These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 6967946)

  • 1. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
    Shaw S; Johnson AH; Shearer GM
    J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-linked B cell alloantigens of a new segregant series: population and family studies of the SB antigens.
    Shaw S; Pollack MS; Payne SM; Johnson AH
    Hum Immunol; 1980 Sep; 1(2):177-85. PubMed ID: 6973559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure.
    Shaw S; DeMars R; Schlossman SF; Smith PL; Lampson LA; Nadler LM
    J Exp Med; 1982 Sep; 156(3):731-43. PubMed ID: 6809881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
    Biddison WE; Shaw S
    Diagn Immunol; 1983; 1(3):112-5. PubMed ID: 6209053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
    Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
    Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens.
    Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
    J Immunol; 1983 Jul; 131(1):152-7. PubMed ID: 6190904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new B-cell alloantigen, TB21, coded for in the HLA-D/DR region.
    Maeda H; Juji T
    Tissue Antigens; 1982 Nov; 20(5):327-34. PubMed ID: 6818712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of insulin-dependent diabetes mellitus (IDD) and the HLA-linked SB system.
    de Jongh BM; Termijtelen A; Bruining GJ; de Vries RR; van Rood JJ
    Tissue Antigens; 1984 Feb; 23(2):87-93. PubMed ID: 6608807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell mediated cytotoxicity against HLA-D region products expressed in monocytes and B lymphocytes. III. Inhibition by monoclonal antibodies and study of an HLA-B/DR recombinant.
    Ball EJ; Feighery CF; Stastny P
    Hum Immunol; 1981 Jul; 2(4):305-13. PubMed ID: 6974159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cells.
    Pawelec G; Shaw S; Schneider M; Rehbein A; Wernet P
    Immunogenetics; 1983; 17(2):179-88. PubMed ID: 6402448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of HLA-DR antigens in restricted cytotoxicity by fetal calf serum-specific human T cells.
    Misko IS; Pope JH; Kane RG; Bashir H; Doran T
    Hum Immunol; 1982 Nov; 5(3):183-97. PubMed ID: 6184349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
    Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
    J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional cell mediated lympholysis: II. Genetics.
    Goeken NE; Thompson JS
    Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell proliferation and expression of MHC class II antigens.
    Brown G; Walker L; Ling NR; Richardson P; Johnson GD; Guy K; Steel CM
    Scand J Immunol; 1984 Apr; 19(4):373-7. PubMed ID: 6610209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.